Glymphatic system impairment in neurological disorders: potential mechanisms and therapeutic targets
- 1Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei Province, China
- 2Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei Province, China. [email protected]
- 3Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei Province, China. [email protected]
Abstract
The glymphatic system is a brain-wide metabolic clearance pathway, orchestrating the removal of neurotoxic wastes via glial-dependent perivascular networks. Mediated by polarized aquaporin-4 (AQP4) channels on astrocytic end-feet, this macroscopic system drives the convective exchange of cerebrospinal fluid (CSF) and interstitial fluid (ISF), establishing a functional coupling between the central nervous system (CNS) and the adaptive immune system. Emerging evidence highlights that glymphatic dysfunction act as both a consequence and a driver of numerous neurological disorders. Neurological pathologies, including neuroinflammation and gliovascular remodeling, compromise the structural and functional integrity of glymphatic architectures. Conversely, glymphatic dysfunction exacerbates neurotoxic wastes accumulation, accelerates disease progression, and perpetuates a pathological positive-feedback loop. Despite growing recognition of this bidirectional relationship, the precise mechanisms remain incompletely understood, and targeted therapeutic strategies are still lacking. In this review, we map the functional architecture of this pathway, from periarteriolar CSF influx to perivenous efflux, and dissect its dependence on critical modulators including sleep-wake rhythms, arterial pulsatility, and aging. Furthermore, we explore novel therapeutic interventions, ranging from AQP4-targeted pharmacological modulation to non-invasive physical approaches, and evaluate their potential to shift clinical paradigms from symptomatic management to disease modification.
Related
- Simultaneous multi-task assessment of five neurological language disorders via cross-corpus multimodal learning
- Roles of endogenous retrovirus- and other LTR retrotransposon-derived proteins and peptides in neurological disorders, oncogenesis, and host defense
- When the Cytoskeleton Fails: Primary Structural Defects Underlying Disorders with Neurological Involvement
- Vision In SyndrOmic Neurodevelopmental disorders-15q (VISiON-15q) study: eye tracking to supplement clinical examination for detection of cerebral/cortical visual impairment in children with Angelman and Duplication of 15q Syndromes
- Pulling Illusion in Individuals with Neurological Disorders
BibTeX
@article{wang2026glymphatic,
title = {{Glymphatic system impairment in neurological disorders: potential mechanisms and therapeutic targets}},
author = {Nannan Wang and Z.H. Liu and Yong Wang and Fei Cao and Da Xu},
journal = {Molecular Biomedicine},
year = {2026},
month = jun,
doi = {10.1186/s43556-026-00489-2},
url = {https://doi.org/10.1186/s43556-026-00489-2},
note = {CC BY},
}
RIS
TY - JOUR
TI - Glymphatic system impairment in neurological disorders: potential mechanisms and therapeutic targets
AU - Nannan Wang
AU - Z.H. Liu
AU - Yong Wang
AU - Fei Cao
AU - Da Xu
PY - 2026
DA - 2026/06/12
JO - Molecular Biomedicine
DO - 10.1186/s43556-026-00489-2
UR - https://doi.org/10.1186/s43556-026-00489-2
AB - The glymphatic system is a brain-wide metabolic clearance pathway, orchestrating the removal of neurotoxic wastes via glial-dependent perivascular networks. Mediated by polarized aquaporin-4 (AQP4) channels on astrocytic end-feet, this macroscopic system drives the convective exchange of cerebrospinal fluid (CSF) and interstitial fluid (ISF), establishing a functional coupling between the central nervous system (CNS) and the adaptive immune system. Emerging evidence highlights that glymphatic dysfunction act as both a consequence and a driver of numerous neurological disorders. Neurological pathologies, including neuroinflammation and gliovascular remodeling, compromise the structural and functional integrity of glymphatic architectures. Conversely, glymphatic dysfunction exacerbates neurotoxic wastes accumulation, accelerates disease progression, and perpetuates a pathological positive-feedback loop. Despite growing recognition of this bidirectional relationship, the precise mechanisms remain incompletely understood, and targeted therapeutic strategies are still lacking. In this review, we map the functional architecture of this pathway, from periarteriolar CSF influx to perivenous efflux, and dissect its dependence on critical modulators including sleep-wake rhythms, arterial pulsatility, and aging. Furthermore, we explore novel therapeutic interventions, ranging from AQP4-targeted pharmacological modulation to non-invasive physical approaches, and evaluate their potential to shift clinical paradigms from symptomatic management to disease modification.
SN - 2662-8651
ER -